There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Larimar Therapeutics
Category: Healthcare
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Ayala Pharmaceuticals (NASDAQ: AYLA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se
JonesTrading Thinks Monopar Therapeutics Inc’s Stock is Going to Recover
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Monopar Therapeutics Inc (MNPR – Research
Maxim Group Reaffirms Their Buy Rating on Dynatronics (DYNT)
In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Dynatronics (DYNT – Research Report),
Stifel Nicolaus Thinks Phasebio Pharmaceuticals’ Stock is Going to Recover
Stifel Nicolaus analyst Derek Archila reiterated a Buy rating on Phasebio Pharmaceuticals (PHAS – Research Report) today and set a
Needham Thinks Phasebio Pharmaceuticals’ Stock is Going to Recover
Needham analyst Chad Messer maintained a Buy rating on Phasebio Pharmaceuticals (PHAS – Research Report) today and set a price
Maxim Group Sticks to Its Buy Rating for Fennec Pharmaceuticals (FENC)
In a report released yesterday, Naureen Quibria from Maxim Group maintained a Buy rating on Fennec Pharmaceuticals (FENC – Research